Helena Dordio is the COO and TechnoPhage’s Qualified Person (QP). Helena has more than 18 years work experience in the pharmaceutical industry, specifically in the multinational companies Janssen-Cilag and Vifor Pharma. Helena has successfully worked in production, new product introduction, and in the quality assurance areas, in which she had the opportunity to lead important projects based on lean manufacturing. Her background is pharmaceutical sciences, also having a master’s degree in advanced pharmacotechnology, and an Executive MBA.
Miguel Garcia, PhD, is co-founder and CEO of TechnoPhage. Miguel has nearly 20 years of experience in the biotech industry in business development, management and finance and intellectual property strategy, executing all entrepreneurial and strategic activities associated to the company. Miguel’s scientific background is based in pharmaceutical sciences, followed by a PhD in pharmacy and an Executive MBA.
Sofia Côrte-Real, PhD, developed her professional career in the area of Health Sciences, developing full scale projects from discovery to clinical phases – preclinical development of drugs, as well as support to technology and strategy development; defining regulatory aspects (ICH guidelines, etc) and interaction with the appropriate bodies (Infarmed, EMA, FDA, etc), in various therapeutic areas using small domain antibodies, bacteriophages and small molecules. Sofia’s scientific background was based on applied chemistry, followed by a PhD in pharmacy.